![Kenneth B. Adler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth B. Adler
Corporate Officer/Principal chez North Carolina State University
Postes actifs de Kenneth B. Adler
Sociétés | Poste | Début | Fin |
---|---|---|---|
North Carolina State University | Corporate Officer/Principal | - | - |
Historique de carrière de Kenneth B. Adler
Anciens postes connus de Kenneth B. Adler
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioMarck Pharmaceuticals Ltd.
![]() BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Directeur Technique/Scientifique/R&D | 25/02/2002 | - |
Fondateur | 20/01/2010 | - |
Formation de Kenneth B. Adler
University of Vermont | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
BioMarck Pharmaceuticals Ltd.
![]() BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Health Technology |
- Bourse
- Insiders
- Kenneth B. Adler
- Expérience